{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:22:52Z","timestamp":1791339772509,"version":"4.3.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1053\/beha.2001.0142","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:24:48Z","timestamp":1027682688000},"page":"437-454","source":"Crossref","is-referenced-by-count":200,"title":["Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease"],"prefix":"10.1053","volume":"14","author":[{"given":"Miha","family":"Furlan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"L\u00e4mmle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2001.0142_RF1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-0609.1996.tb01930.x","article-title":"The pathophysiology and management of thrombotic thrombocytopenic purpura","volume":"56","author":"Ruggenenti","year":"1996","journal-title":"European Journal of Haematology"},{"key":"10.1053\/beha.2001.0142_RF2","first-page":"83","article-title":"Studies on the pathophysiology of thrombotic thrombocytopenic purpura","volume":"34","author":"Moake","year":"1997","journal-title":"Seminars in Hematology"},{"key":"10.1053\/beha.2001.0142_RF3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/0002-9343(75)90510-0","article-title":"Thrombotic thrombocytopenic purpura in four siblings","volume":"38","author":"Wallace","year":"1975","journal-title":"American Journal of Medicine"},{"key":"10.1053\/beha.2001.0142_RF4","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.1976.03260450038030","article-title":"Thrombotic thrombocytopenic purpura. Occurrence two years apart during late pregnancy in two sisters","volume":"235","author":"Fuchs","year":"1976","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/beha.2001.0142_RF5","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1182\/blood.V80.8.1890.bloodjournal8081890","article-title":"Thrombotic microangiopathies in the 80s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic","volume":"80","author":"Thompson","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7326\/0003-4819-93-2-284","article-title":"Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome in HLA-identical siblings","volume":"93","author":"Hellman","year":"1980","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/beha.2001.0142_RF7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/adc.63.6.644","article-title":"Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in three siblings","volume":"63","author":"Elias","year":"1988","journal-title":"Archives of Disease in Childhood"},{"key":"10.1053\/beha.2001.0142_RF8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ki.1987.206","article-title":"HUS and TTP: variable expression of a single entity","volume":"32","author":"Remuzzi","year":"1987","journal-title":"Kidney International"},{"key":"10.1053\/beha.2001.0142_RF9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM199104113241515","article-title":"Epidemiology of the hemolytic uremic syndrome","volume":"324","author":"Ruggenenti","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0142_RF10","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1172\/JCI112107","article-title":"Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma","volume":"76","author":"Siddiqui","year":"1985","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0142_RF11","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake","year":"1982","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0142_RF12","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1182\/blood.V74.3.978.bloodjournal743978","article-title":"Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome","volume":"74","author":"Mannucci","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood.V64.3.592.592","article-title":"Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome","volume":"64","author":"Moake","year":"1984","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF14","doi-asserted-by":"crossref","first-page":"8559","DOI":"10.1016\/S0021-9258(17)39509-1","article-title":"Native conformation of human von Willebrand protein. Analysis by electron microscopy and quasi-elastic light scattering","volume":"260","author":"Slayter","year":"1985","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0142_RF15","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1182\/blood.V88.8.2939.bloodjournal8882939","article-title":"Shear-dependent changes in the three-dimensional structure of human von Willebrand factor","volume":"88","author":"Siedlecki","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.1989.tb00226.x","article-title":"Binding of von Willebrand factor to glycoproteins Ib and IIb\/IIIa complex: affinity is related to multimeric size","volume":"73","author":"Federici","year":"1989","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0142_RF17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(86)90735-X","article-title":"Inducible secretion of large, biologically potent von Willebrand factor multimers","volume":"46","author":"Sporn","year":"1986","journal-title":"Cell"},{"key":"10.1053\/beha.2001.0142_RF18","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1182\/blood.V73.8.2074.2074","article-title":"Multimeric composition of endothelial cell-derived von Willebrand factor","volume":"73","author":"Tsai","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF19","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI112736","article-title":"Involvement of large plasma von Willebrand factor (VWF) multimers and unusually large VWF forms derived from endothelial cells in shear stress-induced platelet aggregation","volume":"78","author":"Moake","year":"1986","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0142_RF20","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1073\/pnas.87.16.6306","article-title":"Identification of a cleavage site directing the immunochemical detection of molecular abnormalitities in type IIA von Willebrand disease","volume":"87","author":"Dent","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0142_RF21","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI115376","article-title":"Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit","volume":"88","author":"Dent","year":"1991","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0142_RF22","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1073\/pnas.90.16.7503","article-title":"Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers","volume":"90","author":"Furlan","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0142_RF23","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF24","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF25","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.V83.8.2171.2171","article-title":"Shear stress enhances the proteolysis of von Willebrand factor in normal plasma","volume":"83","author":"Tsai","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF26","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood.V89.9.3097","article-title":"Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura","volume":"89","author":"Furlan","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0037-1614408","article-title":"Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura","volume":"81","author":"Furlan","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0142_RF28","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood.V91.8.2839.2839_2839_2846","article-title":"Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura","volume":"91","author":"Furlan","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000204850","article-title":"Use of vincristine in refractory thrombotic thrombocytopenic purpura","volume":"85","author":"Levin","year":"1991","journal-title":"Acta Haemotologica"},{"key":"10.1053\/beha.2001.0142_RF30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-0609.1994.tb00649.x","article-title":"Vincristine sulfate for the treatment of thombotic thrombocytopenic purpura refractory to plasma-exchange","volume":"52","author":"Bobbio-Pallavicini","year":"1994","journal-title":"European Journal of Haematology"},{"key":"10.1053\/beha.2001.0142_RF31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s002770050549","article-title":"Vincristine as salvage treatment for refractory thrombotic thrombocytic purpura","volume":"78","author":"Ferrara","year":"1999","journal-title":"Annals of Hematology"},{"key":"10.1053\/beha.2001.0142_RF32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2007-1000391","article-title":"Recovery by splenectomy in patients with relapsed thrombotic thrombocytopenic purpura and treatment failure to plasma exchange","volume":"21","author":"H\u00f6ffkes","year":"1995","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1053\/beha.2001.0142_RF33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.7326\/0003-4819-125-4-199608150-00006","article-title":"Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura","volume":"125","author":"Crowther","year":"1996","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/beha.2001.0142_RF34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/(SICI)1096-8652(199909)62:1<56::AID-AJH10>3.0.CO;2-5","article-title":"Splenectomy during partial remission in thrombotic thrombocytopenic purpura with prolonged plasma exchange dependency","volume":"62","author":"Mant","year":"1999","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0142_RF35","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0142_RF36","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0142_RF37","doi-asserted-by":"crossref","first-page":"794","DOI":"10.7326\/0003-4819-132-10-200005160-00005","article-title":"Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura","volume":"132","author":"Tsai","year":"2000","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/beha.2001.0142_RF38","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200006153422402","article-title":"Thrombotic thrombocytopenic purpura associated with clopidogrel","volume":"342","author":"Bennet","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0142_RF39","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood.V93.11.3798","article-title":"von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura","volume":"93","author":"van der Plas","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF40","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2141.2001.02704.x","article-title":"Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease","author":"Fontana","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0142_RF41","article-title":"von Willebrand factor (VWF)-cleaving protease: changes in health and disease","author":"Mannucci","year":"2000","journal-title":"Workshop on VWF and TTP"},{"key":"10.1053\/beha.2001.0142_RF42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0163-4453(95)90693-2","article-title":"Verocytotoxin-1 induces apoptosis in vero cells","volume":"30","author":"Inward","year":"1995","journal-title":"Journal of Infection"},{"key":"10.1053\/beha.2001.0142_RF43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000025838","article-title":"Glomerular endothelial cell injury mediated by shiga-like toxin","volume":"21","author":"Adler","year":"1998","journal-title":"Kidney and Blood Pressure Research"},{"key":"10.1053\/beha.2001.0142_RF44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1203\/00006450-199901000-00022","article-title":"The detection of shiga toxins in the kidney of a patient with hemolytic uremic syndrome","volume":"45","author":"Uchida","year":"1999","journal-title":"Pediatric Research"},{"key":"10.1053\/beha.2001.0142_RF45","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1086\/515592","article-title":"Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli shiga toxins 1 and 2","volume":"178","author":"Kiyokawa","year":"1998","journal-title":"Journal of Infectious Diseases"},{"key":"10.1053\/beha.2001.0142_RF46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-4274(98)00383-X","article-title":"A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures","volume":"105","author":"Williams","year":"1999","journal-title":"Toxicology Letters"},{"key":"10.1053\/beha.2001.0142_RF47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/adc.78.2.190","article-title":"Advances in hemolytic uremic syndrome","volume":"78","author":"Taylor","year":"1998","journal-title":"Archives of Disease in Childhood"},{"key":"10.1053\/beha.2001.0142_RF48","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V88.1.174.174","article-title":"Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release","volume":"88","author":"van Setten","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF49","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1182\/blood.V95.11.3396","article-title":"Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome","volume":"95","author":"te Loo","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF50","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s004670050515","article-title":"Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H","volume":"12","author":"Ohali","year":"1998","journal-title":"Pediatric Nephrology"},{"key":"10.1053\/beha.2001.0142_RF51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1681\/ASN.V102281","article-title":"Hypocomplementemia discloses genetic predispositon to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities","volume":"10","author":"Noris","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1053\/beha.2001.0142_RF52","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0272-6386(12)81065-1","article-title":"Familial hemolytic uremic syndrome and homozygous factor H deficiency","volume":"24","author":"Pichette","year":"1994","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1053\/beha.2001.0142_RF53","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney International"},{"key":"10.1053\/beha.2001.0142_RF54","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1681\/ASN.V9122318","article-title":"Human complement factor H deficiency associated with hemolytic uremic syndrome","volume":"9","author":"Rougier","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1053\/beha.2001.0142_RF55","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/302673","article-title":"Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome","volume":"65","author":"Ying","year":"1999","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beha.2001.0142_RF56","article-title":"von Willebrand factor-cleaving protease in childhood diarrhoea-associated hemolytic uremic syndrome","author":"Hunt","year":"2001","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0142_RF57","first-page":"134","article-title":"Thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome relapse: frequency, pathogenesis, and meaning","volume":"34","author":"Bell","year":"1997","journal-title":"Seminars in Hematology"},{"key":"10.1053\/beha.2001.0142_RF58","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood.V16.1.943.943","article-title":"Studies on thrombopoiesis. I. A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency","volume":"16","author":"Schulman","year":"1960","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF59","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1182\/blood.V84.2.490.490","article-title":"Solvent\/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura","volume":"84","author":"Moake","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF60","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s004310050855","article-title":"Chronic relapsing thrombotic thrombocytopenic purpura: three case reports and update of the pathogenesis and therapeutic modalities","volume":"157","author":"Maes","year":"1998","journal-title":"European Journal of Pediatrics"},{"key":"10.1053\/beha.2001.0142_RF61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1423-0410.1998.tb05478.x","article-title":"SD plasma in TTP and coagulation factor deficiencies for which no concentrates are available","volume":"74","author":"Horowitz","year":"1998","journal-title":"Vox Sanguinis"},{"key":"10.1053\/beha.2001.0142_RF62","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s004310051234","article-title":"New strategies in diagnosis and treatment of thrombotic thrombocytopenic purpura: case report and review","volume":"158","author":"H\u00e4berle","year":"1999","journal-title":"European Journal of Pediatrics"},{"key":"10.1053\/beha.2001.0142_RF63","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V60.4.1030.1030","article-title":"Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells","volume":"60","author":"Burns","year":"1982","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF64","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(88)92287-8","article-title":"Lytic ant-endothelial cell antibodies in hemolytic-uremic syndrome","volume":"23","author":"Leung","year":"1988","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0142_RF65","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1365-2141.1994.tb05122.x","article-title":"Anti-CD36 antibodies in thrombotic thrombocytopenic purpura","volume":"88","author":"Tandon","year":"1994","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0142_RF66","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-2141.1998.01070.x","article-title":"Anti-CD36 autoantibodies in thrombotic thrombocytopenic purpura and other thrombotic disorders: identification of an 85kD form of CD36 as a target antigen","volume":"103","author":"Schultz","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0142_RF67","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4049\/jimmunol.148.1.78","article-title":"Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro","volume":"148","author":"Swerlick","year":"1992","journal-title":"Journal of Immunology"},{"key":"10.1053\/beha.2001.0142_RF68","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0038-1647462","article-title":"Platelet agglutinating protein p37 causes platelet activation through its binding to membrane glycoprotein IV","volume":"65","author":"Lian","year":"1991","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0142_RF69","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1365-2141.2000.01941.x","article-title":"Management of thrombotic thrombocytopenic purpura","volume":"109","author":"Rock","year":"2000","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0142_RF70","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2141.1994.tb05131.x","article-title":"Anti-CD36 antibodies in patients with lupus anticoagulants and thrombotic complications","volume":"88","author":"Rock","year":"1994","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0142_RF71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/(SICI)1096-8652(199910)62:2<82::AID-AJH3>3.0.CO;2-H","article-title":"Minimal evidence of platelet and endothelial cell reactive antibodies in thrombotic thrombocytopenic purpura","volume":"62","author":"Raife","year":"1999","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0142_RF72","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ajh.2830450407","article-title":"Thrombotic microangiopathy and retroviral infections: a 13 year experience","volume":"45","author":"Ucar","year":"1994","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0142_RF73","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood.V87.8.3245.bloodjournal8783245","article-title":"Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells","volume":"87","author":"Laurence","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF74","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0038-1651644","article-title":"Detection of circulating endothelial cells in thrombotic thrombocytopenic purpura","volume":"69","author":"Lefevre","year":"1993","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0142_RF75","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/blood.V89.4.1224","article-title":"Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells","volume":"89","author":"Mitra","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF76","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/blood.V93.4.1264","article-title":"Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura","volume":"93","author":"Dang","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF77","first-page":"98","article-title":"Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura\/sporadic hemolytic-uremic syndrome","volume":"34","author":"Laurence","year":"1997","journal-title":"Seminars in Hematology"},{"key":"10.1053\/beha.2001.0142_RF78","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0049-3848(98)00151-0","article-title":"Plasma from a patient with thrombotic thrombocytopenic purpura induces endothelial cell apoptosis and platelet aggregation","volume":"93","author":"Wu","year":"1999","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0142_RF79","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/IAI.66.2.636-644.1998","article-title":"Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies","volume":"66","author":"Karpman","year":"1998","journal-title":"Infection and Immunity"},{"key":"10.1053\/beha.2001.0142_RF80","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/BF00868714","article-title":"Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura","volume":"9","author":"Karpman","year":"1995","journal-title":"Pediatric Nephrology"},{"key":"10.1053\/beha.2001.0142_RF81","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s004670050712","article-title":"Circulating inflammatory cytokine levels in hemolytic uremic syndrome","volume":"13","author":"Litalien","year":"1999","journal-title":"Pediatric Nephrology"},{"key":"10.1053\/beha.2001.0142_RF82","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ajh.2830480205","article-title":"Morphologic and ultrastructural evidence for interleukin-6 induced platelet activation","volume":"48","author":"Oleksowicz","year":"1995","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0142_RF83","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1182\/blood.V94.5.1683","article-title":"Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation","volume":"94","author":"Wolf","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF84","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1182\/blood.V75.6.1273.1273","article-title":"Membrane expression of platelet calpain","volume":"75","author":"Schmaier","year":"1990","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF85","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1083\/jcb.120.6.1501","article-title":"Evidence that activation of platelet calpain is induced as a consequence of binding of adhesive ligand to the integrin, glycoprotein IIb-IIIa","volume":"120","author":"Fox","year":"1993","journal-title":"Journal of Cell Biology"},{"key":"10.1053\/beha.2001.0142_RF86","doi-asserted-by":"crossref","first-page":"36321","DOI":"10.1074\/jbc.274.51.36321","article-title":"Inhibition of calpain blocks platelet secretion, aggregation, and spreading","volume":"274","author":"Croce","year":"1999","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0142_RF87","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1182\/blood.V70.5.1683.1683","article-title":"Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura","volume":"70","author":"Murphy","year":"1987","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF88","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1016\/S0021-9258(18)32347-0","article-title":"Purification of human platelet calcium-activated protease. Effect on platelet and endothelial function","volume":"258","author":"Yoshida","year":"1983","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0142_RF89","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2141.1990.tb06335.x","article-title":"Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb\/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura","volume":"74","author":"Moore","year":"1990","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0142_RF90","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood.V80.9.2246.2246","article-title":"Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles","volume":"80","author":"Kelton","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF91","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.bmt.1701928","article-title":"Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura","volume":"24","author":"Zeigler","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2001.0142_RF92","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood.V94.2.610","article-title":"Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predispositon in families","volume":"94","author":"Galbusera","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0142_RF93","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1056\/NEJM198501103120211","article-title":"Hemolytic uremic syndrome\u2014then and now","volume":"312","author":"Drummond","year":"1985","journal-title":"New England Journal of Medicine"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:09:31Z","timestamp":1682140171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692601901422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1521692601901422"],"URL":"https:\/\/doi.org\/10.1053\/beha.2001.0142","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}